REGISTRAT, Inc. strategically designs and implements Late Phase Studies for sponsors to optimize clinical and commercial benefits that contribute to a successful product launch and support ongoing commercialization efforts. REGISTRAT personnel collectively apply years of multidisciplinary experience working specifically with the complexities and nuances of Late Phase Studies (peri- and post-approval studies) and observational databases. REGISTRAT provides sponsors a complete spectrum of integrated research services required for conducting Global Late Phase Studies.
Keywords: Phase IIIb-IV, registries, post-approval, post-marketing, pharmacoepidemiology, epidemiology, risk management, REMS, safety sureveillance, pharmacovigilance, pregnancy registries, observational studies,